Literature DB >> 19794964

Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.

Roman A Blaheta1, Maciej Powerski, Lukasz Hudak, Eva Juengel, Dietger Jonas, Andreas von Knethen, Hans Willhelm Doerr, Jindrich Cinatl.   

Abstract

Tumor cells have evolved effective strategies to escape the host immune response. The objective of this study was to determine whether tumor cells can condition endothelial cells in a specific manner to prevent subsequent adhesion of polymorphonuclear neutrophils (PMNs) and/or peripheral blood lymphocytes (PBLs). Human umbilical vein endothelial cells (HUVECs) and UKF-NB-4 neuroblastoma tumor cells were established in coculture on opposite sides of porous transwell filters. After 24 hours with and without HUVEC conditioning, PMNs or PBLs were added to the HUVEC monolayer. Adhesion to conditioned HUVEC versus adhesion to nonconditioned HUVEC was compared. Effects on endothelial CD44v4, CD44v5, CD44v7, intercellular adhesion molecule 1 (ICAM-1), E-selectin, and vascular cell adhesion molecule 1 (VCAM-1) adhesion receptor expression were analyzed by flow cytometry, intracellular signaling proteins of the mitogen-activated protein kinase pathway and protein kinase C (PKC) subtypes quantified by Western blot analysis. Endothelial conditioning led to a distinct reduction in PMN but not in PBL adhesion to HUVEC. CD44 was significantly reduced, whereas ICAM-1, E-selectin, and VCAM-1 were not altered during HUVEC conditioning. Antibody blockade against CD44v4, CD44v5, and CD44v7 inhibited PMN but not PBL binding. The observed effects were caused by direct tumor cell-HUVEC contact because addition of isolated tumor cell membrane fragments but not of soluble cell culture supernatant to HUVEC induced the CD44 receptor loss. PKCalpha activity was strongly enhanced in conditioned HUVEC. Blocking PKC prevented the reduction in PMN binding, indicating that this protein is involved in PMN adhesion regulation. A novel tumor escape strategy is presented here. Cell contact-dependent adhesion of tumor cells to the vascular wall promotes down-regulation of endothelial CD44 receptor expression, impairing an effective neutrophil attack.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794964      PMCID: PMC2745671          DOI: 10.1593/neo.09762

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  26 in total

Review 1.  The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Authors:  E Di Carlo; G Forni; P Lollini; M P Colombo; A Modesti; P Musiani
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 2.  Shedding light on immunotherapy for cancer.

Authors:  Steven A Rosenberg
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

3.  Diminished leukocyte-endothelium interaction in tumor microvessels.

Authors:  N Z Wu; B Klitzman; R Dodge; M W Dewhirst
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

4.  Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.

Authors:  R L Chen; C P Reynolds; R C Seeger
Journal:  Cancer Immunol Immunother       Date:  2000-02       Impact factor: 6.968

5.  Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing.

Authors:  S Takamizawa; S Okamoto; J Wen; W Bishop; K Kimura; A Sandler
Journal:  J Pediatr Surg       Date:  2000-02       Impact factor: 2.545

6.  Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat.

Authors:  Sasa-Marcel Maksan; Patrick Morad Araib; Eduard Ryschich; Martha Maria Gebhard; Jan Schmidt
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

7.  Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Authors:  Anita E M Dirkx; Mirjam G A Oude Egbrink; Marijke J E Kuijpers; Sandra T van der Niet; Viviane V T Heijnen; Jessica C A Bouma-ter Steege; John Wagstaff; Arjan W Griffioen
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Fas ligand on tumor cells mediates inactivation of neutrophils.

Authors:  Yi-Ling Chen; Shun-Hua Chen; Jiu-Yao Wang; Bei-Chang Yang
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 9.  Immune escape of tumors: apoptosis resistance and tumor counterattack.

Authors:  Frederik H Igney; Peter H Krammer
Journal:  J Leukoc Biol       Date:  2002-06       Impact factor: 4.962

Review 10.  Current developments in cancer vaccines and cellular immunotherapy.

Authors:  Antoni Ribas; Lisa H Butterfield; John A Glaspy; James S Economou
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

View more
  9 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα-p38-SP-1 pathway.

Authors:  Pu Zhang; Chris Goodrich; Changliang Fu; Cheng Dong
Journal:  FASEB J       Date:  2014-08-19       Impact factor: 5.191

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 5.  A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy.

Authors:  Gizem Duru; Marjolein van Egmond; Niels Heemskerk
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

6.  Patterning microscale extracellular matrices to study endothelial and cancer cell interactions in vitro.

Authors:  Laura E Dickinson; Cornelis Lütgebaucks; Daniel M Lewis; Sharon Gerecht
Journal:  Lab Chip       Date:  2012-11-07       Impact factor: 6.799

7.  Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.

Authors:  Eva Juengel; Geraldine Krueger; Jochen Rutz; Karen Nelson; Isabella Werner; Borna Relja; Barbara Seliger; Beate Fisslthaler; Ingrid Fleming; Igor Tsaur; Axel Haferkamp; Roman A Blaheta
Journal:  Oncotarget       Date:  2016-04-12

8.  Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study.

Authors:  Pan Yeung; Hoi Shun Sin; Shing Chan; Godfrey Chi Fung Chan; Barbara Pui Chan
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

9.  Long non-coding RNA GAPLINC promotes angiogenesis by regulating miR-211 under hypoxia in human umbilical vein endothelial cells.

Authors:  Yangyan He; Ziheng Wu; Chenyang Qiu; Xiaohui Wang; Yilang Xiang; Tian Lu; Yunjun He; Tao Shang; Qianqian Zhu; Xun Wang; Qinglong Zeng; Hongkun Zhang; Donglin Li
Journal:  J Cell Mol Med       Date:  2019-10-07       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.